UCLA Department of Radiation Oncology
United States of America (USA)
1 October 2019 - 30 September 2020
Principal institution: UCLA David Geffen School of Medicine (DGSOM)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for UCLA Department of Radiation Oncology published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.53 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.53 | |
Top articles by Altmetric score in current window
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.
Proceedings of the National Academy of Sciences of the United States of America
2020-05-01
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
